Literature DB >> 34051802

The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals.

Gaia Chiara Mannino1, Carolina Averta1, Teresa Vanessa Fiorentino1, Elena Succurro1, Rosangela Spiga1, Elettra Mancuso1, Sofia Miceli1, Maria Perticone1, Angela Sciacqua1, Francesco Andreozzi2, Giorgio Sesti3.   

Abstract

BACKGROUND: Prior studies in animal models showed that increased cardiac expression of TRIB3 has a pathogenic role in inducing left ventricular mass (LVM). Whether alterations in TRIB3 expression or function have a pathogenic role in inducing LVM increase also in humans is still unsettled. In order to address this issue, we took advantage of a nonsynonymous TRIB3 Q84R polymorphism (rs2295490), a gain-of-function amino acid substitution impairing insulin signalling, and action in primary human endothelial cells which has been associated with insulin resistance, and early vascular atherosclerosis.
METHODS: SNP rs2295490 was genotyped in 2426 White adults in whom LVM index (LVMI) was assessed by validated echocardiography-derived measures.
RESULTS: After adjusting for age and sex, LVMI progressively and significantly increased from 108 to 113, to 125 g/m2 in Q84Q, Q84R, and R84R individuals, respectively (Q84R vs. Q84Q, P = 0.03; R84R vs. Q84Q, P < 0.0001). The association between LVMI and the Q84R and R84R genotype remained significant after adjusting for blood pressure, smoking habit, fasting glucose levels, glucose tolerance status, anti-hypertensive treatments, and lipid-lowering therapy (Q84R vs. Q84Q, P = 0.01; R84R vs. Q84Q, P < 0.0001).
CONCLUSIONS: We found that the gain-of-function TRIB3 Q84R variant is significantly associated with left ventricular mass in a large sample of White nondiabetic individual of European ancestry.

Entities:  

Keywords:  Cardiovascular disease; Genetics; Insulin signaling; Left ventricular mass index; TRIB3 Q84R variant; rs2295490

Year:  2021        PMID: 34051802     DOI: 10.1186/s12933-021-01308-4

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  39 in total

1.  Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.

Authors:  F Perticone; R Ceravolo; C Cosco; M Trapasso; A Zingone; P Malatesta; N Perrotti; D Tramontano; P L Mattioli
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

2.  Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.

Authors:  Giorgio Sesti; Angela Sciacqua; Angela Scozzafava; Marco Vatrano; Elvira Angotti; Carmen Ruberto; Elpidio Santillo; Giuseppe Parlato; Francesco Perticone
Journal:  J Hypertens       Date:  2007-02       Impact factor: 4.844

3.  Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension.

Authors:  P Verdecchia; G Reboldi; G Schillaci; C Borgioni; A Ciucci; M P Telera; F Santeusanio; C Porcellati; P Brunetti
Journal:  Circulation       Date:  1999-10-26       Impact factor: 29.690

4.  Accidents in the surgical treatment of varicose veins.

Authors:  R Rettori
Journal:  Phlebologie       Date:  1982 Jan-Mar

5.  Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study.

Authors:  A Ilercil; R B Devereux; M J Roman; M Paranicas; M J O'grady; T K Welty; D C Robbins; R R Fabsitz; B V Howard; E T Lee
Journal:  Am Heart J       Date:  2001-06       Impact factor: 4.749

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Insulin resistance is an important determinant of left ventricular mass in the obese.

Authors:  Z Sasson; Y Rasooly; T Bhesania; I Rasooly
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

8.  52 Genetic Loci Influencing Myocardial Mass.

Authors:  Pim van der Harst; Jessica van Setten; Niek Verweij; Georg Vogler; Lude Franke; Matthew T Maurano; Xinchen Wang; Irene Mateo Leach; Mark Eijgelsheim; Nona Sotoodehnia; Caroline Hayward; Rossella Sorice; Osorio Meirelles; Leo-Pekka Lyytikäinen; Ozren Polašek; Toshiko Tanaka; Dan E Arking; Sheila Ulivi; Stella Trompet; Martina Müller-Nurasyid; Albert V Smith; Marcus Dörr; Kathleen F Kerr; Jared W Magnani; Fabiola Del Greco M; Weihua Zhang; Ilja M Nolte; Claudia T Silva; Sandosh Padmanabhan; Vinicius Tragante; Tõnu Esko; Gonçalo R Abecasis; Michiel E Adriaens; Karl Andersen; Phil Barnett; Joshua C Bis; Rolf Bodmer; Brendan M Buckley; Harry Campbell; Megan V Cannon; Aravinda Chakravarti; Lin Y Chen; Alessandro Delitala; Richard B Devereux; Pieter A Doevendans; Anna F Dominiczak; Luigi Ferrucci; Ian Ford; Christian Gieger; Tamara B Harris; Eric Haugen; Matthias Heinig; Dena G Hernandez; Hans L Hillege; Joel N Hirschhorn; Albert Hofman; Norbert Hubner; Shih-Jen Hwang; Annamaria Iorio; Mika Kähönen; Manolis Kellis; Ivana Kolcic; Ishminder K Kooner; Jaspal S Kooner; Jan A Kors; Edward G Lakatta; Kasper Lage; Lenore J Launer; Daniel Levy; Alicia Lundby; Peter W Macfarlane; Dalit May; Thomas Meitinger; Andres Metspalu; Stefania Nappo; Silvia Naitza; Shane Neph; Alex S Nord; Teresa Nutile; Peter M Okin; Jesper V Olsen; Ben A Oostra; Josef M Penninger; Len A Pennacchio; Tune H Pers; Siegfried Perz; Annette Peters; Yigal M Pinto; Arne Pfeufer; Maria Grazia Pilia; Peter P Pramstaller; Bram P Prins; Olli T Raitakari; Soumya Raychaudhuri; Ken M Rice; Elizabeth J Rossin; Jerome I Rotter; Sebastian Schafer; David Schlessinger; Carsten O Schmidt; Jobanpreet Sehmi; Herman H W Silljé; Gianfranco Sinagra; Moritz F Sinner; Kamil Slowikowski; Elsayed Z Soliman; Timothy D Spector; Wilko Spiering; John A Stamatoyannopoulos; Ronald P Stolk; Konstantin Strauch; Sian-Tsung Tan; Kirill V Tarasov; Bosco Trinh; Andre G Uitterlinden; Malou van den Boogaard; Cornelia M van Duijn; Wiek H van Gilst; Jorma S Viikari; Peter M Visscher; Veronique Vitart; Uwe Völker; Melanie Waldenberger; Christian X Weichenberger; Harm-Jan Westra; Cisca Wijmenga; Bruce H Wolffenbuttel; Jian Yang; Connie R Bezzina; Patricia B Munroe; Harold Snieder; Alan F Wright; Igor Rudan; Laurie A Boyer; Folkert W Asselbergs; Dirk J van Veldhuisen; Bruno H Stricker; Bruce M Psaty; Marina Ciullo; Serena Sanna; Terho Lehtimäki; James F Wilson; Stefania Bandinelli; Alvaro Alonso; Paolo Gasparini; J Wouter Jukema; Stefan Kääb; Vilmundur Gudnason; Stephan B Felix; Susan R Heckbert; Rudolf A de Boer; Christopher Newton-Cheh; Andrew A Hicks; John C Chambers; Yalda Jamshidi; Axel Visel; Vincent M Christoffels; Aaron Isaacs; Nilesh J Samani; Paul I W de Bakker
Journal:  J Am Coll Cardiol       Date:  2016-09-27       Impact factor: 24.094

9.  Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.

Authors:  Martin K Rutter; Helen Parise; Emelia J Benjamin; Daniel Levy; Martin G Larson; James B Meigs; Richard W Nesto; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.